CYTOPATHOLOGY
and generally it is offered in the language of the host country and in English. This does mean that the local hosts must commit to providing someone to translate the MCQs and the clinical histories. However, the examination is often held at the annual EFCS European Congress of Cytology meeting where a wider range of nationalities may be interested in sitting the examination. In an attempt to increase candidate
numbers, the examination recently has been offered in multiple languages, although this does provide a challenge in finding willing translators for potentially small numbers of candidates. In addition, the introductory guidance to candidates delivered as a PowerPoint presentation at the beginning of the examination may require a simultaneous translation in the host venue language. It is clear that some words and phrases simply do not translate easily from English into other languages; for example, the term ‘iatrogenic change’ has caused confusion in many translated papers.
'The 40th European Congress of Cytology meeting and QUATE aptitude test will take place in Liverpool in October'
Perhaps the most complex examination in
recent times was that held in Milan last year (Fig 1, Table 2)
Local support Local support is vital to the success of each QUATE examination. Those initiated by local teams that have been offered annually or biannually work well as there is an existing infrastructure and knowledge of the process. Examinations held at congress and tutorials can be more challenging as the venue and local team may be different each time, and responsibilities may not be clear.
Impact of primary HPV screening Many countries in Europe are further ahead in the move to HPV primary screening than is the UK. For countries where the move from conventional smears to ‘HPV first’ was made, this represents an additional problem; conversion from conventional to LBC for cytology triage. The UK has a structured approach to conversion between technologies and this has been tightened recently with new guidance from the NHS Cervical Screening Programme (NHSCSP). In some countries, however, the resources required to convert from conventional to LBC has been underestimated, and this has been reflected in the results of the QUATE examination. It is clear that supplier conversion on its own is inadequate and additional training is required.
Table 1. Details of the very successful Slovenian examination, held in May 2015.
• 22 candidates
• 19 conventional smears, two SurePath, one ThinPrep
• Two languages • 20/22 passed • Both fails were due to missed dyskaryosis • All Slovenian candidates passed
Table 2. Features of the highly complex examination, held in Milan in 2015.
• 27 candidates • three technologies • four languages
• translation of MCQs, clinical histories, response sheets
• different clinical histories for all technologies
• 29 different documents to prepare
• simultaneous translation of introductory presentation
• all carried out simultaneously in one room.
Pro-Lab Diagnostics is pleased to announce the launch of Cognitor®
The first in a new range of diagnostic products specifically designed for the rapid detection and exclusion of infection, assisting clinicians with: Antibiotic stewardship Improved patient management and outcomes Costs
Cognitor® Minus utilises ETGA® ,a novel technology
Pro-Lab Diagnostics UK 3 Bassendale Road Bromborough
Merseyside CH62 3QL United Kingdom Tel: 0151 353 1613 Fax: 0151 353 1614
Email:
uksupport@pro-lab.com www.pro-lab.co.uk
that delivers: Rapid results Universal detection of all bacteria and fungi Detection of viable organisms only
Up to 90% of blood cultures are negative but take five days to be confirmed as such. Patients suspected of bloodstream infection have samples taken and are routinely placed on high-dose, broad-spectrum, intravenous antibiotics until definitive information is available. In a high number of cases this is precautionary but has a significant impact on costs, care levels and patient outcomes.
Cognitor®
Minus gives a confirmed negative result, direct from blood culture, the day following sample receipt by the laboratory with a negative predictive value (NPV) of 99.5%
Please contact us for further details at
uksupport@pro-lab.com
Minus
THE BIOMEDICAL SCIENTIST AUGUST 2016
423
Pro-Lab
Diagnostics will be running a
Sepsis Seminar at the Hard Day's Night Hotel in Liverpool on the 26th October 2016.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60